Hyderabad pharma firm gets UAE nod to market joint support supplement

First product in nutraceutical segment from India to get approved in UAE, says the company

Updated - November 04, 2023 11:24 am IST - HYDERABAD

Drugmaker Lee Pharma has received marketing authorisation for its joint support supplement Bio-Cartilage Smoothwalk Tablets in the United Arab Emirates.

Describing it as a milestone, the Hyderabad-based company said it is the first product in the nutraceutical segment from India to get approved in the UAE. Bio-Cartilage Smoothwalk Tablets are already being used in India by those suffering from painful and progressive arthritis, director Alla Leela Rani said on Friday.

The company said it is a novel composition of bio nutraceuticals with potent phyto nutrients to prevent joint and connective tissue disorders. The product contains collagen type II, natural egg shell membrane, Boswellia and curcumin with vitamin D3 which mainly acts on joint and connective tissue disorders to increase cartilage in joints.

The product is under registration in all Middle East, East Asian countries. The company plans to file dossier, for marketing authorisation, in the U.S. in the second half of 2024.

0 / 0
Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in

Comments

Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.